Zhenjing H. Jin
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Correction: Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations.
Journal: Frontiers in immunology
Published: July 28, 2026
Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.
Journal: Cardiovascular diabetology
Published: September 23, 2025
Association between metabolic syndrome, fatty liver disease, and gastrointestinal tumors: a population-based study with external validation.
Journal: Frontiers in nutrition
Published: September 17, 2025
Correction: Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient.
Journal: Frontiers in immunology
Published: June 26, 2025
A comprehensive review of IgG4-related pancreatitis: pathogenesis, diagnosis, and therapeutic advances.
Journal: Frontiers in immunology
Published: March 11, 2025
Elevated ascitic interleukin-36 receptor antagonist mediates CD8+T cell exhaustion in vitro in liver cirrhotic patients with spontaneous bacterial peritonitis.
Journal: Immunology letters
Published: March 10, 2025
Progress and Perspectives in Overlapping Primary Biliary Cholangitis and Autoimmune Hepatitis: A Comprehensive Review.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: January 27, 2025
Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient.
Journal: Frontiers in immunology
Published: January 22, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial.
Journal: The Journal of infection
Published: November 10, 2024
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations.
Journal: Frontiers in immunology
Published: October 13, 2024
The neutrophil-lymphocyte ratio as a risk factor for all-cause mortality among individuals with resolved HBV infection: evidence from the NHANES 1999-2018.
Journal: Frontiers in public health
Published: September 09, 2024
Last Updated: 09/26/2026